(Q45076471)

English

A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer

scientific article published in February 2005

Statements

A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit